EMP16
EMP16 has been studied in 1 paper since 2025: 1 trial in people. The newest paper, Aug 6, 2025: “The Supportive Effect of Acarbose to Orlistat in Weight Management-A Randomized, Double-Blind, Multiarm Phase 2 Trial”.
1 paper studies it2 findingsUpdated
At a glance
The findings reach people, from one lab or study. 1 lab in 1 country; 3 trials, 1 about aging, 1 with no results posted.
“EMP16 demonstrating greater improvement in fatty liver index and quality of life compared to Conv-O (p < 0.01)”
None of its findings points the other way.
- 1 lab in 1 country
- 3 trials, 1 about aging, 1 with no results posted
- Funder: Empros Pharma
- 2 of 2 findings with company ties
- 3 of 3 trials sponsored by its developers
- Human trial1
Studies in people
1 study gave EMP16 to people and measured what changed.
| What changed | Design | People | Source |
|---|---|---|---|
up: Improves quality of lifegreater improvement than Conv-O down: Decreases fatty liver indexgreater improvement than Conv-O | Randomized trial6 months | 240 peoplePatient cohorts | Obesity (Silver Spring, Md.), Aug 6, 2025 |
What did studies of EMP16 find?
2Studies of EMP16 measured 2 outcomes: fatty liver index and quality of life.
Fatty liver index
downin humans1
1 study
Fatty liver index
downin humans1
EMP16 decreases fatty liver index in humans (compared with conventional orlistat) (greater improvement than Conv-O).
“EMP16 demonstrating greater improvement in fatty liver index and quality of life compared to Conv-O (p < 0.01)”
Human trialcompared with conventional orlistatliver6 months
Obesity (Silver Spring, Md.)
Quality of life
upin humans1
1 study
Quality of life
upin humans1
EMP16 improves quality of life in humans (compared with conventional orlistat) (greater improvement than Conv-O).
“EMP16 demonstrating greater improvement in fatty liver index and quality of life compared to Conv-O (p < 0.01)”
Human trialcompared with conventional orlistat6 months
Obesity (Silver Spring, Md.)
Has EMP16 been tested in people?
1 of 3 about agingYes: 1 trial in people have been published.
About aging
Study Exploring the Supportive Effect of Acarbose in Weight Management
Phase 2Status unknown